When the Numbers Don’t Tell the Whole Story: Suicide, Dementia, and the Timing of Choice
According to the Centers for Disease Control and Prevention, suicide remains one of the leading causes of death in the United States. In 2023, adults age 85 and older had the highest suicide rate at 22.7 per 100,000, followed by those ages 75 to 84 at 19.4 per 100,000. Combined, adults over 75 represent the highest-risk age group.
Data on methods by age is limited in recent reports, but earlier research suggests that adults over 65 most often used firearms, with a much smaller percentage involving poisoning. While method matters for prevention discussions, it does not fully explain the deeper “why” behind these decisions.
The National Institute of Mental Health also confirms that adults 75 and older have the highest suicide rates of any age group. However, neither the CDC nor NIMH distinguishes between suicides driven by mental health crises and those potentially influenced by terminal illness, cognitive decline, or end-of-life decision-making. Everything is grouped into broad categories such as Firearms, Poisoning, Suffocation, or Other.
That lack of distinction matters.
A study published by the Yale School of Medicine found that adults over 65 diagnosed with Alzheimer’s disease or other forms of dementia are more than twice as likely to die by suicide compared to their peers without dementia. The risk is especially high within the first 90 days following diagnosis, and remains elevated throughout the first year. In fact, suicide deaths during that first year were 53 percent higher than expected compared to the general population.
This raises uncomfortable but necessary questions.
Is this purely a mental health crisis, or are some individuals making a deliberate decision about how they want to face a progressive, incurable disease?
One of the key recommendations from the Yale study was to limit access to firearms and certain medications following a dementia diagnosis. From a clinical safety perspective, that makes sense. But it also highlights a tension that is rarely addressed openly. For some, this is not only about impulsivity or depression. It may also reflect fear of prolonged decline, loss of identity, and loss of autonomy. Personally, I find it appalling that these doctors are more concerned about access to guns.
According to the Mayo Clinic, individuals diagnosed with Alzheimer’s disease typically live between 3 and 11 years after diagnosis. That is not a short window. It can include years of meaningful experiences, relationships, and moments of clarity, especially in the earlier stages.
And yet, the data suggests that many are choosing to end their lives much earlier, often within the first year, sometimes within the first few months.
That disconnect is worth examining.
If someone is acting out of fear immediately after diagnosis, are they being supported well enough to understand what the coming years might still offer? At the same time, if someone later in the disease process wants to make a clear, rational decision about their end-of-life timing, do they have legal, ethical, and humane options available?
Right now, those two very different scenarios are often treated the same.
This is where the conversation needs to evolve.
Better mental health support immediately following a diagnosis could help reduce decisions made in moments of shock, fear, or uncertainty. At the same time, clearer and more compassionate end-of-life legislation could allow individuals to make informed choices later in the disease process, when decline becomes severe and quality of life is significantly diminished.
The goal should not be to push people toward or away from a specific outcome. It should be to give people time, clarity, and dignity, along with real options at the appropriate stage of their journey.
Because when it comes to end-of-life decisions, timing is everything!
Some Referenced Data:
Suicide Data and Statistics
https://www.cdc.gov/suicide/facts/data.html
Suicide is One of the Leading Causes of Death in the United States
https://www.nimh.nih.gov/health/statistics/suicide
Yale Study Finds Elevated Suicide Risk for Older Adults Diagnosed With Dementia
https://medicine.yale.edu/news-article/yale-study-finds-elevated-suicided-risk-for-older-adults-diagnosed-with-dementia/
Alzheimer's stages: How the disease progresses
https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers-stages/art-20048448
Comments
Post a Comment